J. Kevin Buchi - 06 Dec 2023 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director
Signature
/s/ J. Kevin Buchi
Issuer symbol
BNTC
Transactions as of
06 Dec 2023
Transactions value $
$0
Form type
4
Filing time
07 Dec 2023, 19:55:51 UTC
Previous filing
14 Aug 2023
Next filing
06 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +35K $0.00 35K 06 Dec 2023 Common Stock 35K $3.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant.